BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9649622)

  • 1. Allosteric regulation of a ribozyme activity through ligand-induced conformational change.
    Araki M; Okuno Y; Hara Y; Sugiura Y
    Nucleic Acids Res; 1998 Jul; 26(14):3379-84. PubMed ID: 9649622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of allosteric hammerhead ribozymes activated by ligand-induced structure stabilization.
    Soukup GA; Breaker RR
    Structure; 1999 Jul; 7(7):783-91. PubMed ID: 10425680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive regulation of modular allosteric aptazymes by a small molecule and oligonucleotide effector.
    Najafi-Shoushtari SH; Famulok M
    RNA; 2005 Oct; 11(10):1514-20. PubMed ID: 16199761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression mechanism of the allosteric interactions in a ribozyme catalysis.
    Araki M; Okuno Y; Sugiura Y
    Nucleic Acids Symp Ser; 2000; (44):205-6. PubMed ID: 12903340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling between substrate binding and allosteric regulation in ribozyme catalysis.
    Araki M; Hashima M; Okuno Y; Sugiura Y
    Bioorg Med Chem; 2001 May; 9(5):1155-63. PubMed ID: 11377174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction.
    Murray JB; Dunham CM; Scott WG
    J Mol Biol; 2002 Jan; 315(2):121-30. PubMed ID: 11779233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative binding of effectors by an allosteric ribozyme.
    Jose AM; Soukup GA; Breaker RR
    Nucleic Acids Res; 2001 Apr; 29(7):1631-7. PubMed ID: 11266567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of allosteric ribozymes.
    Tang J; Breaker RR
    Chem Biol; 1997 Jun; 4(6):453-9. PubMed ID: 9224568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-active riboswitching: allosteric regulation of ribozyme activity by ligand-shape control.
    Strohbach D; Novak N; Müller S
    Angew Chem Int Ed Engl; 2006 Mar; 45(13):2127-9. PubMed ID: 16502442
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of ribozyme cleavage activity by oligonucleotides.
    Komatsu Y; Ohtsuka E
    Methods Mol Biol; 2004; 252():165-77. PubMed ID: 15017048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.
    Homann M; Tabler M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3951-7. PubMed ID: 7524030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism for allosteric inhibition of an ATP-sensitive ribozyme.
    Tang J; Breaker RR
    Nucleic Acids Res; 1998 Sep; 26(18):4214-21. PubMed ID: 9722642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of hammerhead ribozyme variants with low Mg2+ requirement: importance of stem-loop II.
    Persson T; Hartmann RK; Eckstein F
    Chembiochem; 2002 Nov; 3(11):1066-71. PubMed ID: 12404631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leakage and slow allostery limit performance of single drug-sensing aptazyme molecules based on the hammerhead ribozyme.
    de Silva C; Walter NG
    RNA; 2009 Jan; 15(1):76-84. PubMed ID: 19029309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric hammerhead ribozyme TRAPs.
    Burke DH; Ozerova ND; Nilsen-Hamilton M
    Biochemistry; 2002 May; 41(21):6588-94. PubMed ID: 12022862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.
    Komatsu Y; Yamashita S; Kazama N; Nobuoka K; Ohtsuka E
    J Mol Biol; 2000 Jun; 299(5):1231-43. PubMed ID: 10873448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes.
    Wang DY; Lai BH; Sen D
    J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An allosteric hammerhead ribozyme.
    Porta H; Lizardi PM
    Biotechnology (N Y); 1995 Feb; 13(2):161-4. PubMed ID: 9634757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of modified long-mer RNAs and analysis of FMN binding to the ypaA aptamer from B. subtilis.
    Frommer J; Hieronymus R; Selvi Arunachalam T; Heeren S; Jenckel M; Strahl A; Appel B; Müller S
    RNA Biol; 2014; 11(5):609-23. PubMed ID: 24755604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.